Dextromethorphan hydrobromide 1.5 MG/ML / pyrilamine maleate 1.5 MG/ML Oral Solution — RxCUI 1423307
RxNorm drug concept · Semantic clinical drug
RxCUI 1423307
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1423307
Official nameDextromethorphan hydrobromide 1.5 MG/ML / pyrilamine maleate 1.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextromethorphan hydrobromide 7.5 MG / pyrilamine maleate 7.5 MG per 5 ML Oral Solution; dextromethorphan HBr 7.5 MG / pyrilamine maleate 7.5 MG in 5 mL Oral Solution
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)12,873 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Dextromethorphan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It won't necessarily silence your cough entirely, but it does temporarily suppress the cough reflex and reduce how intense and frequent your cough is. It can also help reduce that...
- What exactly does dextromethorphan do — will it stop my cough completely?
- It depends on your child's age and the specific product. Most dextromethorphan products should not be given to children under 4 years old without a doctor's guidance. Some products...
- This is a really important question. If your antidepressant is an MAOI (monoamine oxidase inhibitor), you absolutely cannot take dextromethorphan — not while you're on it, and not...
🕸️ Concept Web — How Dextromethorphan hydrobromide 1.5 MG/ML / pyrila... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Dextromethorphan hydrobromide 1.5 MG/ML / pyrilamine maleate 1.5 MG/ML Oral Solution
RxCUI 1423307 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Dextromethorphan
3289IN -
Pyrilamine
9009IN -
Dextromethorphan / pyrilamine
1423306MIN -
Dextromethorphan hydrobromide
102490PIN -
Pyrilamine maleate
82091PIN
-
Dextromethorphan
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Dextromethorphan / pyrilamine Oral Solution
1423305SCDF -
Dextromethorphan hydrobromide / pyrilamine maleate Oral Solution
2648848SCDFP -
Dextromethorphan / pyrilamine Oral Liquid Product
1423303SCDG -
Dextromethorphan / pyrilamine Oral Product
1423304SCDG -
Dextromethorphan hydrobromide / pyrilamine maleate Oral Liquid Product
2663436SCDGP -
Dextromethorphan hydrobromide / pyrilamine maleate Oral Product
2660906SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Dextromethorphan / pyrilamine Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Dextromethorphan hydrobromide 1.5 MG/ML
1090505SCDC -
Pyrilamine maleate 1.5 MG/ML
1236170SCDC
-
Dextromethorphan hydrobromide 1.5 MG/ML
Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Dextromethorphan hydrobromide 1.5 MG/ML
SCDC · 1090505 -
Pyrilamine maleate 1.5 MG/ML
SCDC · 1236170 -
Dextromethorphan / pyrilamine Oral Solution
SCDF · 1423305 -
Dextromethorphan hydrobromide / pyrilamine maleate Oral Solution
SCDFP · 2648848 -
Dextromethorphan / pyrilamine Oral Liquid Product
SCDG · 1423303 -
Dextromethorphan / pyrilamine Oral Product
SCDG · 1423304 -
Dextromethorphan hydrobromide / pyrilamine maleate Oral Liquid Product
SCDGP · 2663436 -
Dextromethorphan hydrobromide / pyrilamine maleate Oral Product
SCDGP · 2660906
📦 FDA Products & Package NDCs
2 products · 3 package NDCs
3 package NDCs map to RxCUI 1423307 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 29978-0127-15 | 6 BOTTLE in 1 BOX (29978-127-15) / 15 mL in 1 BOTTLE | Capron DM | Capital Pharmaceutical, LLC | 2013-06-20 |
| 29978-0127-16 | 1 BOTTLE in 1 BOX (29978-127-16) / 473 mL in 1 BOTTLE | Capron DM | Capital Pharmaceutical, LLC | 2013-06-20 |
| 69367-0398-16 | 473 mL in 1 BOTTLE (69367-398-16) | Pyrilamine Maleate and Dextromethorphan Hydrobromide | Westminster Pharmaceuticals, LLC | 2024-07-15 |
Observed labelers:
Capital Pharmaceutical, LLC (2) ·
Westminster Pharmaceuticals, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0672
Range $0.0648–$0.0696
· middle 50% $0.0660–$0.0684
· 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.